EXHIBIT 99.2 JOINT FILING STATEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with...
EXHIBIT 99.2
JOINT FILING STATEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities
Exchange Act of 1934, the undersigned agree to the joint filing of a Statement
on Schedule 13D (including any and all amendments thereto) with respect to the
Common Stock, $0.01 par value, of Duramed Pharmaceuticals, Inc., and further
agree to the filing of this agreement as an Exhibit thereto. In addition, each
party to this Agreement expressly authorizes each other party to this Agreement
to file on its behalf any and all amendments to such Statement on Schedule 13D.
Dated: October 15, 1999
SOLVAY PHARMACEUTICALS, INC.
By: /s/ Xxxxxxx X. Xxxxxx
-------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Vice President, Law,
Government and Public
Affairs
SOLVAY AMERICA, INC.
By: /s/ X.X. Xxxxxxxxxx, XXX
-------------------------------------
Name: X.X. Xxxxxxxxxx, XXX
Title: Vice President, General
Counsel and Secretary
SOLVAY S.A.
By: /s/ Xxxx X. Xxxxxxx
-------------------------------------
Name: Xxxx X. Xxxxxxx
Title: General Manager, Finance
and Corporate Planning
